Calcineurin (CN) inhibitors currently used to avoid transplant rejection block the activation of adaptive immune responses but also prevent the development of tolerance toward the graft, by directly inhibiting T cells. CN, through the transcription factors of the NFAT family, plays an important role also in the differentiation dendritic cells (DCs), the main cells responsible for the activation of T lymphocytes. Therefore, we hypothesized that the inhibition of CN only in DCs and not in T cells could be sufficient to prevent T cell responses, while allowing for the development of tolerance. Here, we show that inhibition of CN/NFAT pathway in innate myeloid cells, using a new nanoconjugate capable of selectively targeting phagocytes in vivo, protects against graft rejection and induces a longer graft acceptance compared to common CN inhibitors. We propose a new generation of nanoparticles-based selective immune suppressive agents for a better control of transplant acceptance.

Colombo, M., Marongiu, L., Mingozzi, F., Marzi, R., Cigni, C., Facchini, F., et al. (2022). Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells. ISCIENCE, 25(10) [10.1016/j.isci.2022.105042].

Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells

Marongiu L.;Mingozzi F.;Marzi R.;Cigni C.;Facchini F. A.;Rotem R.;Valache M.;Gornati L.;Rizzuto M. A.;Salvioni L.;Zanoni I.;Gori A.;Prosperi D.;Granucci F.
2022

Abstract

Calcineurin (CN) inhibitors currently used to avoid transplant rejection block the activation of adaptive immune responses but also prevent the development of tolerance toward the graft, by directly inhibiting T cells. CN, through the transcription factors of the NFAT family, plays an important role also in the differentiation dendritic cells (DCs), the main cells responsible for the activation of T lymphocytes. Therefore, we hypothesized that the inhibition of CN only in DCs and not in T cells could be sufficient to prevent T cell responses, while allowing for the development of tolerance. Here, we show that inhibition of CN/NFAT pathway in innate myeloid cells, using a new nanoconjugate capable of selectively targeting phagocytes in vivo, protects against graft rejection and induces a longer graft acceptance compared to common CN inhibitors. We propose a new generation of nanoparticles-based selective immune suppressive agents for a better control of transplant acceptance.
Articolo in rivista - Articolo scientifico
Drugs; Health sciences; Immune response; Immunology;
English
Colombo, M., Marongiu, L., Mingozzi, F., Marzi, R., Cigni, C., Facchini, F., et al. (2022). Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells. ISCIENCE, 25(10) [10.1016/j.isci.2022.105042].
File in questo prodotto:
File Dimensione Formato  
Colombo-2022-iscience-VoR.pdf

accesso aperto

Descrizione: Article
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 3.47 MB
Formato Adobe PDF
3.47 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/394434
Citazioni
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
Social impact